tartaric acid has been researched along with methylprednisolone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnalich, F; Baos, R; del Fresno, C; Fuentes-Prior, P; García, F; Glaría, A; Gómez-Piña, V; López-Collazo, E; Rodríguez-Rojas, A; Sánchez, M; Soares-Schanoski, A; Vallejo-Cremades, MT | 1 |
1 other study(ies) available for tartaric acid and methylprednisolone
Article | Year |
---|---|
6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis.
Topics: Adrenal Cortex Hormones; Animals; Blotting, Western; Bone Resorption; Cell Differentiation; Cells, Cultured; Down-Regulation; Glucocorticoids; Humans; Immunoenzyme Techniques; Interleukin-1 Receptor-Associated Kinases; Lipopolysaccharides; Macrophages; Methylprednisolone; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Osteoclasts; Osteoporosis; RNA, Messenger; Tartrates | 2007 |